

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of female gonad development (GO:2000194) | 9.72594747 |
| 2 | renal absorption (GO:0070293) | 9.68104866 |
| 3 | diterpenoid biosynthetic process (GO:0016102) | 9.09060146 |
| 4 | axoneme assembly (GO:0035082) | 9.08459906 |
| 5 | left/right pattern formation (GO:0060972) | 8.33377343 |
| 6 | extracellular regulation of signal transduction (GO:1900115) | 7.24450064 |
| 7 | extracellular negative regulation of signal transduction (GO:1900116) | 7.24450064 |
| 8 | negative regulation of complement activation (GO:0045916) | 6.98846620 |
| 9 | terpenoid biosynthetic process (GO:0016114) | 6.45959734 |
| 10 | cardiovascular system development (GO:0072358) | 6.35154395 |
| 11 | regulation of cilium movement (GO:0003352) | 6.33564422 |
| 12 | sensory perception of smell (GO:0007608) | 6.32414926 |
| 13 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 6.16479056 |
| 14 | left/right axis specification (GO:0070986) | 6.15090102 |
| 15 | retinoic acid metabolic process (GO:0042573) | 5.96166625 |
| 16 | negative regulation of protein activation cascade (GO:2000258) | 5.95739122 |
| 17 | ventricular system development (GO:0021591) | 5.81088926 |
| 18 | microtubule bundle formation (GO:0001578) | 5.71232453 |
| 19 | negative regulation of humoral immune response (GO:0002921) | 5.55492187 |
| 20 | intraciliary transport (GO:0042073) | 5.49806972 |
| 21 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 5.48644768 |
| 22 | tolerance induction (GO:0002507) | 5.39244304 |
| 23 | O-glycan processing (GO:0016266) | 5.27914638 |
| 24 | lung epithelium development (GO:0060428) | 5.27155807 |
| 25 | cilium organization (GO:0044782) | 5.10238740 |
| 26 | cilium assembly (GO:0042384) | 4.96281266 |
| 27 | sperm capacitation (GO:0048240) | 4.89418764 |
| 28 | activation of MAPKKK activity (GO:0000185) | 4.88167198 |
| 29 | positive regulation of tolerance induction (GO:0002645) | 4.82768822 |
| 30 | retinol metabolic process (GO:0042572) | 4.76573341 |
| 31 | centriole assembly (GO:0098534) | 4.75734147 |
| 32 | establishment of apical/basal cell polarity (GO:0035089) | 4.72622533 |
| 33 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.71728136 |
| 34 | negative regulation of B cell mediated immunity (GO:0002713) | 4.71728136 |
| 35 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.59926629 |
| 36 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.59499994 |
| 37 | glomerular epithelial cell development (GO:0072310) | 4.55732620 |
| 38 | response to xenobiotic stimulus (GO:0009410) | 4.50479917 |
| 39 | regulation of germinal center formation (GO:0002634) | 4.43938571 |
| 40 | L-ascorbic acid metabolic process (GO:0019852) | 4.39896264 |
| 41 | amyloid precursor protein catabolic process (GO:0042987) | 4.25241014 |
| 42 | regulation of interleukin-5 production (GO:0032674) | 4.21223324 |
| 43 | sulfur amino acid catabolic process (GO:0000098) | 4.17553981 |
| 44 | valine metabolic process (GO:0006573) | 4.16671695 |
| 45 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 4.16187574 |
| 46 | protein localization to cilium (GO:0061512) | 4.04729038 |
| 47 | establishment of monopolar cell polarity (GO:0061162) | 4.02757631 |
| 48 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.02757631 |
| 49 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 4.01584056 |
| 50 | microtubule-based movement (GO:0007018) | 3.99645680 |
| 51 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.94921827 |
| 52 | regulation of interleukin-13 production (GO:0032656) | 3.84020615 |
| 53 | establishment of planar polarity (GO:0001736) | 3.79438763 |
| 54 | establishment of tissue polarity (GO:0007164) | 3.79438763 |
| 55 | primary alcohol metabolic process (GO:0034308) | 3.75533919 |
| 56 | cytoplasmic microtubule organization (GO:0031122) | 3.72155533 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.69632573 |
| 58 | cell projection assembly (GO:0030031) | 3.69569101 |
| 59 | regulation of microtubule-based movement (GO:0060632) | 3.66731841 |
| 60 | atrioventricular valve morphogenesis (GO:0003181) | 3.66633490 |
| 61 | hypotonic response (GO:0006971) | 3.66542796 |
| 62 | oligosaccharide biosynthetic process (GO:0009312) | 3.64690051 |
| 63 | progesterone metabolic process (GO:0042448) | 3.63091942 |
| 64 | endocardial cushion morphogenesis (GO:0003203) | 3.58956351 |
| 65 | sensory perception of chemical stimulus (GO:0007606) | 3.54937261 |
| 66 | cilium morphogenesis (GO:0060271) | 3.51149116 |
| 67 | one-carbon compound transport (GO:0019755) | 3.50305163 |
| 68 | vitamin transmembrane transport (GO:0035461) | 3.49393883 |
| 69 | negative regulation of epidermis development (GO:0045683) | 3.48084275 |
| 70 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.45859356 |
| 71 | positive regulation of coagulation (GO:0050820) | 3.43769788 |
| 72 | surfactant homeostasis (GO:0043129) | 3.41858410 |
| 73 | exogenous drug catabolic process (GO:0042738) | 3.37783594 |
| 74 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.35193151 |
| 75 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.32658570 |
| 76 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.32532185 |
| 77 | polyol transport (GO:0015791) | 3.31860989 |
| 78 | positive regulation of osteoblast proliferation (GO:0033690) | 3.29338671 |
| 79 | excretion (GO:0007588) | 3.27855991 |
| 80 | xenobiotic catabolic process (GO:0042178) | 3.26510401 |
| 81 | positive regulation of wound healing (GO:0090303) | 3.25833387 |
| 82 | uronic acid metabolic process (GO:0006063) | 3.23134308 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.23134308 |
| 84 | positive regulation of steroid biosynthetic process (GO:0010893) | 3.21989899 |
| 85 | lymphangiogenesis (GO:0001946) | 3.20386357 |
| 86 | cytokine production involved in immune response (GO:0002367) | 3.19231458 |
| 87 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.18389188 |
| 88 | positive regulation of hemostasis (GO:1900048) | 3.17263099 |
| 89 | positive regulation of blood coagulation (GO:0030194) | 3.17263099 |
| 90 | toxin metabolic process (GO:0009404) | 3.13082636 |
| 91 | ovulation cycle (GO:0042698) | 3.12260030 |
| 92 | glutathione derivative biosynthetic process (GO:1901687) | 3.12107382 |
| 93 | glutathione derivative metabolic process (GO:1901685) | 3.12107382 |
| 94 | fatty acid oxidation (GO:0019395) | 3.11080217 |
| 95 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.09253956 |
| 96 | negative regulation of inclusion body assembly (GO:0090084) | 3.07887274 |
| 97 | iron ion import (GO:0097286) | 3.06801817 |
| 98 | peptide catabolic process (GO:0043171) | 3.05939110 |
| 99 | lipid oxidation (GO:0034440) | 3.04514042 |
| 100 | regulation of keratinocyte proliferation (GO:0010837) | 3.04418563 |
| 101 | protein O-linked glycosylation (GO:0006493) | 3.03641258 |
| 102 | apoptotic cell clearance (GO:0043277) | 3.03049782 |
| 103 | microtubule depolymerization (GO:0007019) | 3.02121650 |
| 104 | ear development (GO:0043583) | 3.00779710 |
| 105 | axonemal dynein complex assembly (GO:0070286) | 20.3474009 |
| 106 | retinal metabolic process (GO:0042574) | 2.98995624 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97106411 |
| 108 | amyloid precursor protein metabolic process (GO:0042982) | 2.97005256 |
| 109 | microtubule polymerization or depolymerization (GO:0031109) | 2.96782735 |
| 110 | phospholipid homeostasis (GO:0055091) | 2.96527749 |
| 111 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.95058345 |
| 112 | chemical homeostasis within a tissue (GO:0048875) | 2.94252525 |
| 113 | aldehyde catabolic process (GO:0046185) | 2.91024536 |
| 114 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.89927061 |
| 115 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88109270 |
| 116 | * multicellular organismal water homeostasis (GO:0050891) | 2.86678611 |
| 117 | sodium ion homeostasis (GO:0055078) | 2.85750653 |
| 118 | reactive oxygen species biosynthetic process (GO:1903409) | 2.84592607 |
| 119 | lateral ventricle development (GO:0021670) | 2.84170174 |
| 120 | regulation of microtubule depolymerization (GO:0031114) | 2.83365863 |
| 121 | cellular copper ion homeostasis (GO:0006878) | 2.82952161 |
| 122 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.82824454 |
| 123 | acute inflammatory response (GO:0002526) | 2.81558176 |
| 124 | positive regulation of macrophage activation (GO:0043032) | 2.81367421 |
| 125 | hydrogen peroxide catabolic process (GO:0042744) | 2.79778279 |
| 126 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.77745770 |
| 127 | opioid receptor signaling pathway (GO:0038003) | 2.76460629 |
| 128 | chemosensory behavior (GO:0007635) | 2.75702385 |
| 129 | tachykinin receptor signaling pathway (GO:0007217) | 2.74809675 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 2.72386512 |
| 131 | regulation of keratinocyte differentiation (GO:0045616) | 2.72194035 |
| 132 | positive regulation of digestive system process (GO:0060456) | 2.71583397 |
| 133 | alcohol catabolic process (GO:0046164) | 2.67729787 |
| 134 | mesenchyme morphogenesis (GO:0072132) | 2.65650550 |
| 135 | hormone catabolic process (GO:0042447) | 2.65642899 |
| 136 | positive regulation of p38MAPK cascade (GO:1900745) | 2.64800460 |
| 137 | lateral sprouting from an epithelium (GO:0060601) | 2.64713334 |
| 138 | drug catabolic process (GO:0042737) | 2.64136341 |
| 139 | regulation of response to osmotic stress (GO:0047484) | 2.63911160 |
| 140 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.63868312 |
| 141 | positive regulation of respiratory burst (GO:0060267) | 2.62668197 |
| 142 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.62067906 |
| 143 | carnitine metabolic process (GO:0009437) | 2.59470149 |
| 144 | beta-amyloid metabolic process (GO:0050435) | 2.58995590 |
| 145 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.55550302 |
| 146 | gas transport (GO:0015669) | 2.55344717 |
| 147 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.55295252 |
| 148 | hydrogen peroxide metabolic process (GO:0042743) | 2.55085906 |
| 149 | sperm motility (GO:0030317) | 2.51131661 |
| 150 | intestinal epithelial cell development (GO:0060576) | 2.51112202 |
| 151 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.50868867 |
| 152 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.48101292 |
| 153 | apical protein localization (GO:0045176) | 2.47892122 |
| 154 | positive regulation of extracellular matrix organization (GO:1903055) | 2.47491889 |
| 155 | high-density lipoprotein particle remodeling (GO:0034375) | 2.45880349 |
| 156 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.45844318 |
| 157 | negative regulation of hormone metabolic process (GO:0032351) | 2.45844318 |
| 158 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.40378329 |
| 159 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.36664892 |
| 160 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.36394126 |
| 161 | regulation of cardioblast proliferation (GO:0003264) | 2.36394126 |
| 162 | xenobiotic metabolic process (GO:0006805) | 2.35816050 |
| 163 | folic acid transport (GO:0015884) | 2.35605208 |
| 164 | vagina development (GO:0060068) | 2.35253854 |
| 165 | positive regulation of steroid metabolic process (GO:0045940) | 2.34962827 |
| 166 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.33594250 |
| 167 | sequestering of metal ion (GO:0051238) | 2.32246651 |
| 168 | protein carboxylation (GO:0018214) | 2.31626972 |
| 169 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.31626972 |
| 170 | heart valve morphogenesis (GO:0003179) | 2.30178885 |
| 171 | positive regulation of macrophage cytokine production (GO:0060907) | 2.30102085 |
| 172 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.29766487 |
| 173 | phenylpropanoid metabolic process (GO:0009698) | 2.28957234 |
| 174 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.28096299 |
| 175 | ethanol oxidation (GO:0006069) | 19.1575448 |
| 176 | primary alcohol catabolic process (GO:0034310) | 16.2755428 |
| 177 | cilium or flagellum-dependent cell motility (GO:0001539) | 15.8200137 |
| 178 | cilium movement (GO:0003341) | 14.2293109 |
| 179 | ethanol metabolic process (GO:0006067) | 13.5608128 |
| 180 | motile cilium assembly (GO:0044458) | 13.2565315 |
| 181 | epithelial cilium movement (GO:0003351) | 12.4450586 |
| 182 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 12.1956884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.93288636 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.84400865 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.57280588 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.39868804 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.17732395 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.15528373 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.14191253 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.65015978 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.57654980 |
| 10 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.56770071 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.54502151 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.53442056 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36224845 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.33550669 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.31750172 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13413337 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.07447018 |
| 18 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.02039368 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00938817 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.98410923 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95094035 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94890256 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93760997 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.88443074 |
| 25 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.83206062 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79144064 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78067653 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77066911 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.72199308 |
| 30 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.72199308 |
| 31 | RXR_22108803_ChIP-Seq_LS180_Human | 1.69860937 |
| 32 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68860313 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54448897 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.54354267 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54276477 |
| 36 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.53264856 |
| 37 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51266780 |
| 38 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.50883680 |
| 39 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.49759183 |
| 40 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.46905914 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46215359 |
| 42 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44717339 |
| 43 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.41110511 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39865679 |
| 45 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.39043136 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37906406 |
| 47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.37317877 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37300236 |
| 49 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.37226361 |
| 50 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.35005283 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34245933 |
| 52 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.34067790 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33425353 |
| 54 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29767538 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26819266 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26033351 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25549452 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24843551 |
| 59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22817108 |
| 60 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.21527360 |
| 61 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.21150516 |
| 62 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.20641068 |
| 63 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.20508881 |
| 64 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20036125 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19079359 |
| 66 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.18484823 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17736364 |
| 68 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.15945425 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15031731 |
| 70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13811464 |
| 71 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13326825 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11934178 |
| 73 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.11120651 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.11120651 |
| 75 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10995880 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10718583 |
| 77 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09564813 |
| 78 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09125877 |
| 79 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08731734 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08704083 |
| 81 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08366412 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.06298619 |
| 83 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.06162579 |
| 84 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.06012578 |
| 85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05285212 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04231338 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02246542 |
| 88 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02127843 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01597118 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00872480 |
| 91 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00733398 |
| 92 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99975648 |
| 93 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99849284 |
| 94 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.99265216 |
| 95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99078640 |
| 96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99078640 |
| 97 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98930803 |
| 98 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98600255 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98600255 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96880792 |
| 101 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96292503 |
| 102 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.96045786 |
| 103 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95714178 |
| 104 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.95330163 |
| 105 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95321062 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95317915 |
| 107 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95014956 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94746928 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94712727 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93787472 |
| 111 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93237382 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92909606 |
| 113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.92812179 |
| 114 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92041078 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91892101 |
| 116 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91655463 |
| 117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91640128 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90447104 |
| 119 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90372822 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88738838 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88378315 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88252591 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87393754 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86956666 |
| 125 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85344564 |
| 126 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.85209068 |
| 127 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84969772 |
| 128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84508744 |
| 129 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84052730 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83461711 |
| 131 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82977152 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82890968 |
| 133 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82256433 |
| 134 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82148314 |
| 135 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81848177 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81674152 |
| 137 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81398415 |
| 138 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.81374353 |
| 139 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.80492623 |
| 140 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80463229 |
| 141 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.79343981 |
| 142 | TP53_16413492_ChIP-PET_HCT116_Human | 0.78204986 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77466066 |
| 144 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.77299205 |
| 145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77291262 |
| 146 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.77172845 |
| 147 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.76476896 |
| 148 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76166590 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76087922 |
| 150 | NFYA_21822215_ChIP-Seq_K562_Human | 0.75768746 |
| 151 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.75590908 |
| 152 | P300_27268052_Chip-Seq_Bcells_Human | 0.73040770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 8.85314347 |
| 2 | MP0004043_abnormal_pH_regulation | 5.94757921 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 4.41135920 |
| 4 | MP0001984_abnormal_olfaction | 4.25315664 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.92458359 |
| 6 | MP0000566_synostosis | 3.07573913 |
| 7 | MP0002132_abnormal_respiratory_system | 2.97065136 |
| 8 | MP0008789_abnormal_olfactory_epithelium | 2.94219937 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.88817831 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 2.86236159 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.67552611 |
| 12 | MP0006054_spinal_hemorrhage | 2.66110942 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.64041261 |
| 14 | MP0004133_heterotaxia | 2.55326480 |
| 15 | MP0005623_abnormal_meninges_morphology | 2.54861267 |
| 16 | MP0003828_pulmonary_edema | 2.49766594 |
| 17 | MP0005409_darkened_coat_color | 2.49191887 |
| 18 | MP0001346_abnormal_lacrimal_gland | 2.44580610 |
| 19 | MP0010678_abnormal_skin_adnexa | 2.41872485 |
| 20 | MP0005499_abnormal_olfactory_system | 2.35775504 |
| 21 | MP0005394_taste/olfaction_phenotype | 2.35775504 |
| 22 | MP0000383_abnormal_hair_follicle | 2.26809425 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 2.18001892 |
| 24 | MP0002168_other_aberrant_phenotype | 2.09144621 |
| 25 | MP0003186_abnormal_redox_activity | 2.07964059 |
| 26 | MP0003329_amyloid_beta_deposits | 2.05791756 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.86904953 |
| 28 | MP0009379_abnormal_foot_pigmentation | 1.65478912 |
| 29 | MP0001188_hyperpigmentation | 1.60454281 |
| 30 | MP0002282_abnormal_trachea_morphology | 1.60053617 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.59458263 |
| 32 | MP0003303_peritoneal_inflammation | 1.51002194 |
| 33 | MP0005365_abnormal_bile_salt | 1.50691842 |
| 34 | MP0005408_hypopigmentation | 1.50671768 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.48561579 |
| 36 | MP0003724_increased_susceptibility_to | 1.44505406 |
| 37 | MP0005377_hearing/vestibular/ear_phenot | 1.44400537 |
| 38 | MP0003878_abnormal_ear_physiology | 1.44400537 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.43358980 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.39126616 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.38509153 |
| 42 | MP0005310_abnormal_salivary_gland | 1.38170239 |
| 43 | MP0002160_abnormal_reproductive_system | 1.36552139 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.31206765 |
| 45 | MP0003941_abnormal_skin_development | 1.31119410 |
| 46 | MP0002295_abnormal_pulmonary_circulatio | 1.29118918 |
| 47 | MP0005395_other_phenotype | 1.26118715 |
| 48 | MP0000371_diluted_coat_color | 1.25434520 |
| 49 | MP0001915_intracranial_hemorrhage | 1.25004598 |
| 50 | MP0000858_altered_metastatic_potential | 1.24652476 |
| 51 | MP0005388_respiratory_system_phenotype | 1.23991797 |
| 52 | MP0002133_abnormal_respiratory_system | 1.23991797 |
| 53 | MP0001756_abnormal_urination | 1.23727679 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.21798164 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.20044303 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.19384918 |
| 57 | MP0005165_increased_susceptibility_to | 1.17852056 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.17367109 |
| 59 | MP0004858_abnormal_nervous_system | 1.17045848 |
| 60 | MP0009764_decreased_sensitivity_to | 1.15240236 |
| 61 | MP0001849_ear_inflammation | 1.12780841 |
| 62 | MP0001958_emphysema | 1.12105124 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.11484772 |
| 64 | MP0000604_amyloidosis | 1.11183933 |
| 65 | MP0003075_altered_response_to | 1.10979378 |
| 66 | MP0002254_reproductive_system_inflammat | 1.10915071 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.10658469 |
| 68 | MP0003279_aneurysm | 1.09347394 |
| 69 | MP0003633_abnormal_nervous_system | 1.09083799 |
| 70 | MP0004883_abnormal_blood_vessel | 1.09037888 |
| 71 | MP0009278_abnormal_bone_marrow | 1.08543940 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.07848915 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.06722364 |
| 74 | MP0000681_abnormal_thyroid_gland | 1.05250876 |
| 75 | MP0002249_abnormal_larynx_morphology | 1.04989012 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.04881627 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 1.02347741 |
| 78 | MP0005085_abnormal_gallbladder_physiolo | 0.99329441 |
| 79 | MP0005503_abnormal_tendon_morphology | 0.97997395 |
| 80 | MP0008004_abnormal_stomach_pH | 0.96819246 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 0.96505423 |
| 82 | MP0000613_abnormal_salivary_gland | 0.96216377 |
| 83 | MP0005164_abnormal_response_to | 0.92190396 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.90069316 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.89743623 |
| 86 | MP0003866_abnormal_defecation | 0.86739167 |
| 87 | MP0002735_abnormal_chemical_nociception | 0.85710647 |
| 88 | MP0005166_decreased_susceptibility_to | 0.85240754 |
| 89 | MP0000249_abnormal_blood_vessel | 0.83688528 |
| 90 | MP0003690_abnormal_glial_cell | 0.83300225 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.81339007 |
| 92 | MP0001177_atelectasis | 0.80013891 |
| 93 | MP0001270_distended_abdomen | 0.77177689 |
| 94 | MP0009763_increased_sensitivity_to | 0.75673324 |
| 95 | MP0005387_immune_system_phenotype | 0.75221581 |
| 96 | MP0001790_abnormal_immune_system | 0.75221581 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.74530289 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.72576922 |
| 99 | MP0001542_abnormal_bone_strength | 0.72284055 |
| 100 | MP0003631_nervous_system_phenotype | 0.71369048 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 0.68205025 |
| 102 | MP0002734_abnormal_mechanical_nocicepti | 0.68019079 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.67778163 |
| 104 | MP0001186_pigmentation_phenotype | 0.67690810 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.67078857 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.66370315 |
| 107 | MP0003632_abnormal_nervous_system | 0.65842489 |
| 108 | MP0001666_abnormal_nutrient_absorption | 0.65469704 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.65127172 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.64923344 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.64454366 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.63166336 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.62986995 |
| 114 | MP0005397_hematopoietic_system_phenotyp | 0.62986995 |
| 115 | MP0001502_abnormal_circadian_rhythm | 0.62721087 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.62527295 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.61931217 |
| 118 | MP0003890_abnormal_embryonic-extraembry | 0.60854933 |
| 119 | MP0002075_abnormal_coat/hair_pigmentati | 0.60447080 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.59771933 |
| 121 | MP0002233_abnormal_nose_morphology | 0.59291314 |
| 122 | MP0005083_abnormal_biliary_tract | 0.59200280 |
| 123 | MP0001664_abnormal_digestion | 0.58838627 |
| 124 | MP0002118_abnormal_lipid_homeostasis | 0.58423830 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.58073723 |
| 126 | MP0002128_abnormal_blood_circulation | 0.56061173 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.56059003 |
| 128 | MP0002796_impaired_skin_barrier | 0.54627710 |
| 129 | MP0001968_abnormal_touch/_nociception | 0.54139672 |
| 130 | MP0005389_reproductive_system_phenotype | 0.54115163 |
| 131 | MP0008995_early_reproductive_senescence | 0.53590374 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.52978236 |
| 133 | MP0001216_abnormal_epidermal_layer | 0.52807027 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.52760364 |
| 135 | MP0002405_respiratory_system_inflammati | 0.52710897 |
| 136 | MP0010630_abnormal_cardiac_muscle | 0.52689664 |
| 137 | MP0000579_abnormal_nail_morphology | 0.51576915 |
| 138 | MP0009053_abnormal_anal_canal | 0.49948844 |
| 139 | MP0002060_abnormal_skin_morphology | 0.48922906 |
| 140 | MP0004272_abnormal_basement_membrane | 0.48098607 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.48070341 |
| 142 | MP0005025_abnormal_response_to | 0.47223360 |
| 143 | MP0003045_fibrosis | 0.46995870 |
| 144 | MP0001663_abnormal_digestive_system | 0.46568225 |
| 145 | MP0003300_gastrointestinal_ulcer | 0.46126894 |
| 146 | MP0000678_abnormal_parathyroid_gland | 0.44834054 |
| 147 | MP0005023_abnormal_wound_healing | 0.44172841 |
| 148 | MP0000343_altered_response_to | 0.43370295 |
| 149 | MP0006082_CNS_inflammation | 0.43368671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 8.51380617 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 7.64668460 |
| 3 | Bronchiectasis (HP:0002110) | 7.56965973 |
| 4 | Large eyes (HP:0001090) | 7.16691468 |
| 5 | Hyperaldosteronism (HP:0000859) | 7.16286036 |
| 6 | Nasal polyposis (HP:0100582) | 6.79815750 |
| 7 | Metabolic alkalosis (HP:0200114) | 6.78585719 |
| 8 | Tetany (HP:0001281) | 6.35063228 |
| 9 | Abnormality of renin-angiotensin system (HP:0000847) | 6.22183560 |
| 10 | Renal salt wasting (HP:0000127) | 6.16788696 |
| 11 | Polydipsia (HP:0001959) | 6.15231350 |
| 12 | Abnormal drinking behavior (HP:0030082) | 6.15231350 |
| 13 | Abnormality of chloride homeostasis (HP:0011422) | 6.01593763 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 5.64715133 |
| 15 | Hypomagnesemia (HP:0002917) | 5.56425489 |
| 16 | Abnormality of magnesium homeostasis (HP:0004921) | 5.11826141 |
| 17 | Impaired platelet aggregation (HP:0003540) | 5.11700120 |
| 18 | Abnormal platelet function (HP:0011869) | 5.11700120 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.64418376 |
| 20 | Bronchitis (HP:0012387) | 4.55578015 |
| 21 | Recurrent sinusitis (HP:0011108) | 4.32503205 |
| 22 | Hypercalciuria (HP:0002150) | 4.29826331 |
| 23 | Chronic sinusitis (HP:0011109) | 4.21292832 |
| 24 | Infertility (HP:0000789) | 4.19015116 |
| 25 | Hypokalemia (HP:0002900) | 4.15709174 |
| 26 | Decreased circulating renin level (HP:0003351) | 4.04024855 |
| 27 | Scanning speech (HP:0002168) | 4.03674872 |
| 28 | Male infertility (HP:0003251) | 4.01449950 |
| 29 | Alkalosis (HP:0001948) | 3.97573520 |
| 30 | Recurrent otitis media (HP:0000403) | 3.91146421 |
| 31 | Chondrocalcinosis (HP:0000934) | 3.87887154 |
| 32 | Polyuria (HP:0000103) | 3.86839237 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 3.81948914 |
| 34 | Abnormal urine output (HP:0012590) | 3.69718952 |
| 35 | Abnormality of Sharpey fibers (HP:0100685) | 3.64410360 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.54443235 |
| 37 | Abnormality of renal excretion (HP:0011036) | 3.49991723 |
| 38 | Adrenal overactivity (HP:0002717) | 3.46854778 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 3.31687338 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.30309705 |
| 41 | Chronic otitis media (HP:0000389) | 3.23348130 |
| 42 | Hypotension (HP:0002615) | 3.22962831 |
| 43 | Occipital encephalocele (HP:0002085) | 3.19530947 |
| 44 | Abnormality of potassium homeostasis (HP:0011042) | 3.14158854 |
| 45 | Atelectasis (HP:0100750) | 3.02008827 |
| 46 | Syncope (HP:0001279) | 2.92662703 |
| 47 | Pancreatic fibrosis (HP:0100732) | 2.89209792 |
| 48 | True hermaphroditism (HP:0010459) | 2.86095358 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 2.78109470 |
| 50 | Esophageal atresia (HP:0002032) | 2.70134374 |
| 51 | Upper motor neuron abnormality (HP:0002127) | 2.42318827 |
| 52 | Cystic liver disease (HP:0006706) | 2.37236322 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.29575286 |
| 54 | Pancreatic cysts (HP:0001737) | 2.25526854 |
| 55 | Esophageal varix (HP:0002040) | 2.22127383 |
| 56 | Abnormality of midbrain morphology (HP:0002418) | 2.21396757 |
| 57 | Molar tooth sign on MRI (HP:0002419) | 2.21396757 |
| 58 | Nephronophthisis (HP:0000090) | 2.18018954 |
| 59 | Nephrocalcinosis (HP:0000121) | 2.14166489 |
| 60 | Absent frontal sinuses (HP:0002688) | 2.13502793 |
| 61 | Tubulointerstitial nephritis (HP:0001970) | 2.13318339 |
| 62 | Postaxial foot polydactyly (HP:0001830) | 2.05912018 |
| 63 | Bell-shaped thorax (HP:0001591) | 2.04079477 |
| 64 | Chronic hepatic failure (HP:0100626) | 2.03362741 |
| 65 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 12.6020050 |
| 66 | Hyperactive renin-angiotensin system (HP:0000841) | 11.0632761 |
| 67 | Abnormal respiratory motile cilium morphology (HP:0005938) | 11.0496282 |
| 68 | Abnormal respiratory epithelium morphology (HP:0012253) | 11.0496282 |
| 69 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.9983639 |
| 70 | Abnormal ciliary motility (HP:0012262) | 10.5625346 |
| 71 | Rhinitis (HP:0012384) | 10.4029022 |
| 72 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.3553902 |
| 73 | Absent/shortened dynein arms (HP:0200106) | 10.3553902 |
| 74 | Progressive visual loss (HP:0000529) | 1.99777286 |
| 75 | Atrioventricular block (HP:0001678) | 1.99395675 |
| 76 | Chronic bronchitis (HP:0004469) | 1.97156914 |
| 77 | Palpitations (HP:0001962) | 1.96770046 |
| 78 | Prolonged QT interval (HP:0001657) | 1.96361410 |
| 79 | Polycythemia (HP:0001901) | 1.92808459 |
| 80 | Stridor (HP:0010307) | 1.91082971 |
| 81 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.90473761 |
| 82 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89854159 |
| 83 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89854159 |
| 84 | Abnormal hemoglobin (HP:0011902) | 1.89402845 |
| 85 | Osteomalacia (HP:0002749) | 1.88473928 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 1.87671102 |
| 87 | Generalized muscle weakness (HP:0003324) | 1.87460097 |
| 88 | Clumsiness (HP:0002312) | 1.86528326 |
| 89 | Decreased subcutaneous fat (HP:0001002) | 1.84797820 |
| 90 | Ulnar bowing (HP:0003031) | 1.84592213 |
| 91 | Dehydration (HP:0001944) | 1.84495171 |
| 92 | Popliteal pterygium (HP:0009756) | 1.83393903 |
| 93 | Abnormality of binocular vision (HP:0011514) | 1.80041352 |
| 94 | Diplopia (HP:0000651) | 1.80041352 |
| 95 | Abnormality of the renal medulla (HP:0100957) | 1.77859672 |
| 96 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.77653818 |
| 97 | Recurrent bronchitis (HP:0002837) | 1.77529459 |
| 98 | Onycholysis (HP:0001806) | 1.76876844 |
| 99 | Lip pit (HP:0100267) | 1.76070023 |
| 100 | Paresthesia (HP:0003401) | 1.73165867 |
| 101 | Congenital hepatic fibrosis (HP:0002612) | 1.72414118 |
| 102 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.72048513 |
| 103 | Male pseudohermaphroditism (HP:0000037) | 1.71123372 |
| 104 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.71121539 |
| 105 | Orchitis (HP:0100796) | 1.67393951 |
| 106 | Asplenia (HP:0001746) | 1.66801797 |
| 107 | Dysphonia (HP:0001618) | 1.66091772 |
| 108 | Anencephaly (HP:0002323) | 1.64500164 |
| 109 | Gastrointestinal atresia (HP:0002589) | 1.63742404 |
| 110 | Hyperkalemia (HP:0002153) | 1.63032558 |
| 111 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.62892872 |
| 112 | Abnormal atrioventricular conduction (HP:0005150) | 1.62062707 |
| 113 | Renal cortical cysts (HP:0000803) | 1.58905215 |
| 114 | Nephropathy (HP:0000112) | 1.58070640 |
| 115 | Heart block (HP:0012722) | 1.55291649 |
| 116 | Renal tubular acidosis (HP:0001947) | 1.53669671 |
| 117 | Long foot (HP:0001833) | 1.52639605 |
| 118 | Hyponatremia (HP:0002902) | 1.51480278 |
| 119 | Abnormality of the corticospinal tract (HP:0002492) | 1.51471677 |
| 120 | Furrowed tongue (HP:0000221) | 1.50519245 |
| 121 | Medial flaring of the eyebrow (HP:0010747) | 1.49223076 |
| 122 | Intention tremor (HP:0002080) | 1.47215606 |
| 123 | Spastic tetraparesis (HP:0001285) | 1.46458860 |
| 124 | Abnormal EKG (HP:0003115) | 1.46386699 |
| 125 | Personality changes (HP:0000751) | 1.45242784 |
| 126 | Tubular atrophy (HP:0000092) | 1.43823693 |
| 127 | Annular pancreas (HP:0001734) | 1.42450874 |
| 128 | Postural tremor (HP:0002174) | 1.42029149 |
| 129 | Diaphragmatic weakness (HP:0009113) | 1.41047511 |
| 130 | Congenital primary aphakia (HP:0007707) | 1.39787707 |
| 131 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.39404596 |
| 132 | Median cleft lip (HP:0000161) | 1.39403551 |
| 133 | Tachypnea (HP:0002789) | 1.39290292 |
| 134 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.38943198 |
| 135 | Oculomotor apraxia (HP:0000657) | 1.38730160 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.37710899 |
| 137 | Abnormality of the motor neurons (HP:0002450) | 1.37209033 |
| 138 | Abnormal neuron morphology (HP:0012757) | 1.37209033 |
| 139 | Hand muscle atrophy (HP:0009130) | 1.35298763 |
| 140 | Gait imbalance (HP:0002141) | 1.34867881 |
| 141 | Abnormality of the frontal sinuses (HP:0002687) | 1.34402533 |
| 142 | Osteopenia (HP:0000938) | 1.33446992 |
| 143 | Flat acetabular roof (HP:0003180) | 1.33378334 |
| 144 | Fragile skin (HP:0001030) | 1.31132722 |
| 145 | Abnormality of permanent molar morphology (HP:0011071) | 1.30261150 |
| 146 | Abnormality of the dental root (HP:0006486) | 1.30261150 |
| 147 | Taurodontia (HP:0000679) | 1.30261150 |
| 148 | Prominent forehead (HP:0011220) | 1.29521560 |
| 149 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.29284823 |
| 150 | Bowing of the arm (HP:0006488) | 1.29117600 |
| 151 | Bowed forearm bones (HP:0003956) | 1.29117600 |
| 152 | Bronchomalacia (HP:0002780) | 1.28843225 |
| 153 | Axonal loss (HP:0003447) | 1.28132036 |
| 154 | Supernumerary nipples (HP:0002558) | 1.27804028 |
| 155 | Postaxial hand polydactyly (HP:0001162) | 1.27594831 |
| 156 | Short hallux (HP:0010109) | 1.26669054 |
| 157 | Cone-rod dystrophy (HP:0000548) | 1.26551041 |
| 158 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.26037254 |
| 159 | Supraventricular tachycardia (HP:0004755) | 1.25927055 |
| 160 | Lower limb hyperreflexia (HP:0002395) | 1.25541919 |
| 161 | Ventricular arrhythmia (HP:0004308) | 1.25357388 |
| 162 | Amyloidosis (HP:0011034) | 1.25027365 |
| 163 | Sclerocornea (HP:0000647) | 1.25012071 |
| 164 | Bifid scrotum (HP:0000048) | 1.24566242 |
| 165 | Small for gestational age (HP:0001518) | 1.24010981 |
| 166 | Short thorax (HP:0010306) | 1.22296569 |
| 167 | Glucose intolerance (HP:0000833) | 1.22053981 |
| 168 | Short nail (HP:0001799) | 1.21595334 |
| 169 | Abnormality of molar (HP:0011077) | 1.20075466 |
| 170 | Abnormality of molar morphology (HP:0011070) | 1.20075466 |
| 171 | Nephrogenic diabetes insipidus (HP:0009806) | 1.18822662 |
| 172 | Abnormality of sodium homeostasis (HP:0010931) | 1.18629230 |
| 173 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.18432442 |
| 174 | Fetal akinesia sequence (HP:0001989) | 1.17998920 |
| 175 | Abnormality of the dental pulp (HP:0006479) | 1.16282129 |
| 176 | Spinal muscular atrophy (HP:0007269) | 1.13070731 |
| 177 | Spinal cord compression (HP:0002176) | 1.12666824 |
| 178 | Carpal bone hypoplasia (HP:0001498) | 1.11484409 |
| 179 | Hypoplastic labia majora (HP:0000059) | 1.11289595 |
| 180 | Tubulointerstitial abnormality (HP:0001969) | 1.09771930 |
| 181 | Aplasia of the musculature (HP:0100854) | 1.07063068 |
| 182 | Decreased central vision (HP:0007663) | 1.05656545 |
| 183 | Muscle fiber splitting (HP:0003555) | 1.03920847 |
| 184 | Short femoral neck (HP:0100864) | 1.03666406 |
| 185 | Facial cleft (HP:0002006) | 1.03657490 |
| 186 | Obstructive sleep apnea (HP:0002870) | 1.03438188 |
| 187 | Abnormality of the labia majora (HP:0012881) | 0.99845389 |
| 188 | Preaxial hand polydactyly (HP:0001177) | 0.99455202 |
| 189 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 0.99093114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 6.85394681 |
| 2 | SIK1 | 5.21994721 |
| 3 | MST4 | 5.05040269 |
| 4 | SIK2 | 4.89298382 |
| 5 | EPHA2 | 4.46221378 |
| 6 | SGK3 | 3.73477983 |
| 7 | SGK2 | 3.44612021 |
| 8 | TYRO3 | 3.30993394 |
| 9 | SGK494 | 2.96582603 |
| 10 | SGK223 | 2.96582603 |
| 11 | ADRBK2 | 2.68867187 |
| 12 | PRKD3 | 2.39259890 |
| 13 | SMG1 | 2.34906801 |
| 14 | STK24 | 2.27303294 |
| 15 | MARK3 | 2.06660177 |
| 16 | MAPKAPK3 | 2.00619609 |
| 17 | ERN1 | 1.91650442 |
| 18 | MST1R | 1.88371576 |
| 19 | PDK2 | 1.68150248 |
| 20 | STK10 | 1.64983701 |
| 21 | TAOK1 | 1.61857573 |
| 22 | MAP3K12 | 1.44501824 |
| 23 | ERBB3 | 1.41917473 |
| 24 | INSRR | 1.40182873 |
| 25 | MAPK15 | 1.37821078 |
| 26 | LRRK2 | 1.32794128 |
| 27 | DAPK2 | 1.32164827 |
| 28 | TTK | 1.25837461 |
| 29 | RPS6KB2 | 1.24991508 |
| 30 | EEF2K | 1.21374977 |
| 31 | EPHB2 | 1.15165541 |
| 32 | PAK3 | 1.14046759 |
| 33 | NEK6 | 1.13069805 |
| 34 | HIPK2 | 1.08593181 |
| 35 | BCR | 1.04187831 |
| 36 | EPHB1 | 1.02143497 |
| 37 | PTK2B | 0.99456435 |
| 38 | MARK2 | 0.95190295 |
| 39 | STK38L | 0.94592325 |
| 40 | RIPK1 | 0.93485256 |
| 41 | CDK6 | 0.93331099 |
| 42 | MAP3K7 | 0.90289706 |
| 43 | TBK1 | 0.88890987 |
| 44 | STK39 | 0.88257908 |
| 45 | PBK | 0.87268656 |
| 46 | MAP2K2 | 0.83110369 |
| 47 | ADRBK1 | 0.82393877 |
| 48 | LATS1 | 0.81647278 |
| 49 | MAP2K3 | 0.80389772 |
| 50 | PDK3 | 0.77221948 |
| 51 | PDK4 | 0.77221948 |
| 52 | PINK1 | 0.73262841 |
| 53 | EPHA3 | 0.72516326 |
| 54 | FGFR3 | 0.72460443 |
| 55 | ICK | 0.72058610 |
| 56 | PRKG2 | 0.67693530 |
| 57 | MET | 0.66667791 |
| 58 | GRK6 | 0.66135419 |
| 59 | ERBB2 | 0.66014362 |
| 60 | KSR2 | 0.64021494 |
| 61 | RIPK4 | 0.63164571 |
| 62 | SGK1 | 0.62681796 |
| 63 | TGFBR2 | 0.59398955 |
| 64 | MAP3K3 | 0.59265656 |
| 65 | CAMKK1 | 0.57823255 |
| 66 | TLK1 | 0.57292495 |
| 67 | TYK2 | 0.54479805 |
| 68 | WNK4 | 0.54007041 |
| 69 | TRPM7 | 0.52900695 |
| 70 | PNCK | 0.52895913 |
| 71 | BRSK2 | 0.51745736 |
| 72 | DYRK1B | 0.50964869 |
| 73 | NTRK3 | 0.50352315 |
| 74 | MAP2K1 | 0.49290658 |
| 75 | FER | 0.49262688 |
| 76 | TIE1 | 0.49253158 |
| 77 | NLK | 0.47526175 |
| 78 | BMPR2 | 0.47486708 |
| 79 | STK38 | 0.47180557 |
| 80 | NME1 | 0.46773050 |
| 81 | ROCK2 | 0.45712083 |
| 82 | NEK9 | 0.43220774 |
| 83 | PRKCH | 0.42997470 |
| 84 | PRKAA2 | 0.42996405 |
| 85 | ZAP70 | 0.42861248 |
| 86 | PRKCE | 0.42390384 |
| 87 | PRKD2 | 0.41397052 |
| 88 | PRKD1 | 0.40479774 |
| 89 | MAP3K2 | 0.39972180 |
| 90 | STK16 | 0.38871989 |
| 91 | PRKCI | 0.38675188 |
| 92 | LATS2 | 0.38365143 |
| 93 | CAMK2D | 0.38134245 |
| 94 | OXSR1 | 0.34748348 |
| 95 | TTN | 0.34639264 |
| 96 | BCKDK | 0.34566648 |
| 97 | PRKCD | 0.34255877 |
| 98 | PAK4 | 0.34058566 |
| 99 | MYLK | 0.33634021 |
| 100 | TESK1 | 0.33374224 |
| 101 | KSR1 | 0.32545380 |
| 102 | FYN | 0.31600011 |
| 103 | CAMK2B | 0.31196673 |
| 104 | MINK1 | 0.31100073 |
| 105 | DMPK | 0.31097763 |
| 106 | CSK | 0.30111420 |
| 107 | WNK1 | 0.29834121 |
| 108 | ABL1 | 0.28295811 |
| 109 | PAK6 | 0.27668871 |
| 110 | TRIB3 | 0.26031019 |
| 111 | PIM2 | 0.25970916 |
| 112 | EGFR | 0.25890435 |
| 113 | JAK1 | 0.25832892 |
| 114 | MAP3K4 | 0.25501276 |
| 115 | CDC42BPA | 0.24557421 |
| 116 | IRAK1 | 0.24483205 |
| 117 | PRKCG | 0.23146113 |
| 118 | MAPK13 | 0.22401359 |
| 119 | MATK | 0.22308389 |
| 120 | MELK | 0.22205236 |
| 121 | SRC | 0.21856262 |
| 122 | SCYL2 | 0.21635217 |
| 123 | CDK8 | 0.21480446 |
| 124 | IKBKE | 0.21382924 |
| 125 | AURKA | 0.20047824 |
| 126 | ALK | 0.19901726 |
| 127 | PRKCQ | 0.19847493 |
| 128 | TAOK2 | 0.19558641 |
| 129 | MAPKAPK5 | 0.19294666 |
| 130 | PRKCA | 0.18595818 |
| 131 | DYRK1A | 0.18579134 |
| 132 | LMTK2 | 0.18449647 |
| 133 | CAMK2A | 0.17682543 |
| 134 | AKT2 | 0.17511305 |
| 135 | CAMK1 | 0.17322662 |
| 136 | CAMKK2 | 0.16931097 |
| 137 | IGF1R | 0.16835843 |
| 138 | CAMK2G | 0.16744811 |
| 139 | PTK6 | 0.16425877 |
| 140 | CDK9 | 0.16108370 |
| 141 | YES1 | 0.15846985 |
| 142 | FGFR4 | 0.15705281 |
| 143 | CSNK1G2 | 0.15087571 |
| 144 | PDGFRB | 0.14244880 |
| 145 | MAP2K6 | 0.14004334 |
| 146 | PHKG1 | 0.13892924 |
| 147 | PHKG2 | 0.13892924 |
| 148 | TEC | 0.13407298 |
| 149 | PRKACA | 0.13061472 |
| 150 | GRK1 | 0.12939370 |
| 151 | PTK2 | 0.12867250 |
| 152 | INSR | 0.12253248 |
| 153 | PDPK1 | 0.11800280 |
| 154 | TNIK | 0.11564972 |
| 155 | MAP3K6 | 0.11075592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 5.91229684 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.16448683 |
| 3 | Tyrosine metabolism_Homo sapiens_hsa00350 | 4.47535054 |
| 4 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 4.47382586 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.82998782 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.48044980 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.16248936 |
| 8 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.90315681 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.74300822 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.63969141 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.53752518 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.38696764 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.21712687 |
| 14 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.16198555 |
| 15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.09824222 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.85810776 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.83569614 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.80708189 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80121055 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.69505335 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.51048305 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37934998 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.34091897 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25411581 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21655953 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17430902 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.15300627 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14924839 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94753750 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 0.86770423 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84906150 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84521524 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81466789 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77447951 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77107654 |
| 36 | Protein export_Homo sapiens_hsa03060 | 0.73229673 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71190748 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70924985 |
| 39 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66057922 |
| 40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63242148 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61707537 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61503552 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60963522 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 0.59704447 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59592176 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58537542 |
| 47 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57427626 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57138991 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56501987 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 0.56065121 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53880905 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52590831 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51018958 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48640753 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47666294 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.47361054 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.46917131 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45853110 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43894077 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.43560308 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.42992181 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42745443 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42569184 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42404549 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42043048 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40954755 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40689183 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40630812 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40519504 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39643598 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39371357 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39341509 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39141595 |
| 74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38903658 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38184127 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37278149 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36264326 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35787514 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.32965139 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.32799227 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32747315 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31787155 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31329612 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.31290505 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30527065 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.29513981 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28290814 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26724057 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.26677580 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26603552 |
| 91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.26177082 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25802586 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.25447840 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24866388 |
| 95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23711828 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.23373524 |
| 97 | Taste transduction_Homo sapiens_hsa04742 | 0.22971872 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.22937255 |
| 99 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.21110657 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.20819052 |
| 101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20709157 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19801308 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.19082708 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.18808261 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.18640801 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18352484 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.18144399 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.17771727 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.17527165 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.17105832 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.16649325 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16602577 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.15737255 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.14293622 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.14143203 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.13787494 |
| 117 | GABAergic synapse_Homo sapiens_hsa04727 | 0.13555142 |
| 118 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13455573 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13234641 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13155144 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.13122736 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.12852836 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.12222056 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.12195198 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12191919 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.12115080 |
| 127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11532007 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.11306770 |
| 129 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.10930948 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.10744969 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.10345905 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.09834854 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.09745230 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09594173 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09255406 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.08206799 |
| 137 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.07378763 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07284939 |
| 139 | Axon guidance_Homo sapiens_hsa04360 | 0.06976599 |
| 140 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.06705661 |
| 141 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.06177215 |
| 142 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.06073150 |
| 143 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.05879704 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.05354676 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.05195902 |
| 146 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.04896748 |
| 147 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.04463931 |
| 148 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04371617 |
| 149 | Cocaine addiction_Homo sapiens_hsa05030 | 0.04260591 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04172060 |
| 151 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04122343 |

